| Product Name |
Losartan Inhouse Impurity 7 / Des[2'-(1H-tetrazol-5-yl)] 2-Cyanolosartan
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals, Aromatics, Amines, drug analogues |
| CAS No |
114772-55-3 |
| Catalog Number |
GS.50.LOS.37 |
| Chemical Name/Synonyms |
4'-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]-[1,1'-biphenyl]-2-carbonitrile ; 2-Butyl-4-chloro-1-[(2'-cyanobiphenyl-4-yl)methyl]-5-hydroxymethylimidazole ; 4'-(2-Butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)-1,1'-biphenyl-2-carbonitrile |
| Molecular Weight |
379.88 |
| Molecular Formula |
C22H22ClN3O |
| Purity |
NLT 95 % |
| Appearance |
White to Off-White Solid |
| Solubility |
DMSO, Ethyl Acetate |
| Applications |
Des[2’-(1H-tetrazol-5-yl)] 2-Cyanolosartan is a derivative of Losartan Potassium, a an angiotensin II antagonist and is commonly used to significantly reduce risk of new onset atrial fibrillation and associated stroke in high-risk patients. |
| Inventory Status |
QC Pending
|
